Access to Covid-19 Vaccine: Patents vs. People?
References
- BACCHUS, James. An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines, 16 December 2020. [online]. Available at:
- BAKER, Brook K. A Sliver of Hope: Analyzing Voluntary Licenses to Accelerate Affordable Access to Medicines. Northeastern University Law Review, 2018, vol. 10, no. 2, pp. 226–315. [online]. Available at:
- BBC News. Coronavirus vaccine delays halt Pfizer jabs in parts of Europe, 23 January 2021. [online]. Available at:
- BRACHMANN, Steve. WHO’s C-TAP Initiative Pushes for Non-Exclusive Global Licensing Amid Pharma Industry Concerns. IPWatchdog.com, 31 May 2020. [online]. Available at:
- BUCHER, Gabriela, REED, Tim. Letter to Dr Tedros: Leadership and Advocacy for C-TAP, 21 January 2021. [online]. Available at:
- BURRONE, Esteban. Patent Pooling in Public Health. The Cambridge Handbook on Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development (Chapter 5), last revised 25 April 2019. [online]. Available at:
- BYRNE, Jane. Compulsory licensing is not an effective policy tool, warns EU biopharma group as it reacts to European IP action plan, 26 November 2020. [online]. Available at:
- COHEN, Shlomo. Compulsory Licensing of Patents – The Paris Convention Model. IDEA: The Journal of Law and Technology, 1979, vol. 20, no. 2, pp. 153–190.
- COLLIS, Helen. AstraZeneca: Coronavirus vaccine deliveries to EU reduced. Politico, 22 January 2021. [online]. Available at:
- COX, Krista L. The Medicines Patent Pool: Promoting Access and Innovation for Life-Saving Medicines Through Voluntary Licenses. Hastings Science and Technology Law Journal, 2012, vol. 4, no. 2, pp. 293–326. [online]. Available at:
- DEUTSCH, Jillian. European Commission publishes AstraZeneca vaccine contract. Politico, 29 January 2021. [online]. Available at:
- DEUTSCH, Jillian, EDER, Florian, HERSZENHORN, David M. Enraged at AstraZeneca over shortfall, EU calls for vaccine export controls. Politico, 26 January 2021. [online]. Available at:
- ENGELHARDT, Jordan, NADIPURAM, Joyce. WTO to Discuss Member Proposal to Waive IP Rights for COVID-19 Technologies. JDSUPRA, 7 January 2021. [online]. Available at:
- European Commission. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: Making the most of the EU’s innovative potential. An intellectual property action plan to support the EU’s recovery and resilience, Brussels, 25.11.2020, COM(2020) 760 final. [online]. Available at:
- European Commission. Press statement by Commissioner Kyriakides on vaccine deliveries and on the vaccine export transparency scheme, 25 January 2021. [online]. Available at:
- European Parliament. News. Covid-19 vaccinations: more solidarity and transparency needed, 19.01.2021. Available at:
- FORD, Sara M. Compulsory Licensing Provisions under the TRIPs Agreement: Balancing Pills and Patents. American University of International Law Review, 2000, vol. 15, no. 4, pp. 941–974.
- GAVI. COVAX explained, 3 September 2020. [online]. Available at:
- Gilead Sciences. Voluntary Licensing Agreements for Remdesivir. [online]. Available at:
- GROSSE RUSE-KHAN, Henning. Access to Covid-19 Treatment and International Intellectual Property Protection – Part I: Patent protection, voluntary access and compulsory licensing, 15 April 2020. Available at:
- The Guardian. US and UK ‘lead push against global patent pool for Covid-19 drugs. Available, 17 May 2020. [online]. Available at:
- GURRY, Francis. Intellectual property, innovation, access and COVID-19. WIPO Magazine, June 2020. [online]. Available at:
- HU, Weinian. Compulsory Licensing and Access to Future COVID-19 Vaccines. CEPS Research Report, no. 2020, 2 July 2020. [online]. Available at:
- International Monetary Fund. Reopening from the Great Lockdown: Uneven and Uncertain Recovery, 24 June 2020. [online]. Available at:
- Joint Research Centre. [online]. Available at:
- LABONTE, Ronald, JOHRI, Mira. COVID-19 drug and vaccine patents are putting profit before people. The Conversation, 5 November 2020. [online]. Available at:
- Marrakesh Agreement Establishing the World Trade Organization of 15 April 1994. [online]. Available at:
- Medecins Sans Frontieres (Access Campaign). Press Release supporting this initiative. [online]. Available at:
- Medecins Sans Frontiers. A Fair Shot for Vaccine Affordability – Understanding and addressing the effects of patents on access to newer vaccines, September 2017. [online]. Available at:
- Medecins Sans Frontieres. India and South Africa proposal for WTO waiver from intellectual property protections for COVID-19-related medical technologies. Briefing Document, updated 18 November 2020. [online]. Available at:
- Medicines Patent Pool. Access to Medicines Tracker. [online]. Available at:
- Medicines Patent Pool. Founders. [online]. Available at:
- Medicines Patent Pool. Licenses. [online]. Available at:
- Medicines Patent Pool. MPP and the Joint Research Centre of the European Commission partner in the field of intellectual property for COVID-19 and beyond, 18 January 2021. [online]. Available at:
- Medicines Patent Pool. Medicines Patent Pool – Frequently Asked Questions (FAQs), 1 June 2018. [online]. Available at:
- Medicines Patent Pool. The Medicines Patent Pool and Unitaid respond to access efforts for COVID-19 treatments and technologies, 31 March 2020. [online]. Available at:
- MedsPal. Medicines Patent Pool. [online]. Available at:
- MURTHY, Divya. The Future of Compulsory Licensing: Deciphering the Doha Declaration on the TRIPs Agreement and Public Health. American University International Law Review, 2002, vol. 17, no. 6, pp. 1300–1346. [online]. Available at:
- Oxfam International. Small group of rich nations have bought up more than half the future supply of leading COVID-19 vaccine contenders, 17 September 2020. [online]. Available at:
- Paris Convention for the Protection of Industrial Property of March 20, 1883, as revised at Brussels on December 14, 1900, at Washington on June 2, 1911, at The Hague on November 6, 1925, at London on June 2, 1934, at Lisbon on October 31, 1958, and at Stockholm on July 14, 1967, and as amended on September 28, 1979.
- PATNAIK, Priti. TRIPS Council informal meeting on TRIPS Waiver proposal. Geneva Health Files, 3 December 2020. [online]. Available at:
- Permanent Mission of the European Union to the World Trade Organization (WTO). EU Statements at the WTO General Council, 18 December 2020. [online]. Available at:
- Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems. Official Journal of the European Union L 157 of 9 June 2006.
- REN, Grace. Progress On COVID-19 Technology Pool Inches Along As Sister Initiative To Pool Vaccine Procurement Accelerates, 25 September 2020. [online]. Available at:
- SAHA, Subhasis. Patent law and TRIPS: Compulsory licensing of patents and pharmaceuticals. Journal of the Patent and Trademark Office Society, 2009, vol. 91, no. 5, pp. 364 et al.
- SILVERMAN, Ed. Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products, 28 May 2020. [online]. Available at:
- SIMON, James H. M., CLAASSEN, Eric, CORREA, Carmen E. and OSTERHAUS, Albert. Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling. Bulletin of the World Health Organization, September 2005, vol. 83, no. 9, pp. 707–710.
- SPERBACK, Ashley E. A Mathematical Solution to the Sine of Madness That Is Pharmaceutical Compulsory Licensing under the TRIPS Agreement and the Doha Declaration. Marquette Intellectual Property Law Review, 2019, vol. 23, no. 1, pp. 21–56.
- ’T HOEN, Ellen. Covid-19 and the comeback of compulsory licensing. Medicines Law and Policy, 23 March 2020. [online]. Available at:
- ’T HOEN, Ellen. The elephant in the room at the WHO Executive Board, 22 January 2021. [online]. Available at:
- ’T HOEN, Ellen. The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14 October 2020. [online]. Available at:
- ’T HOEN, Ellen. The Medicines Patent Pool at 10: from crazy concept to real results. Medicines Patent Pool, 10 December 2020. [online]. Available at:
- ’T HOEN, Ellen. Private patents and public health. Changing intellectual property rules for access to medicines, 2016. [online]. Available at:
- ’T HOEN, Ellen. Some Surprises in the European Commission’s New Intellectual Property Strategy. Medicines Law and Policy, 2 December 2020. [online]. Available at:
- Third World Network. Civil society letter supporting proposal by India and South Africa on waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19. [online]. Available at:
- THRASHER, Rachel. TRIPS agreement: A waiver makes the COVID-19 vaccine more accessible. Open Access Government, 25 November 2020. [online]. Available at:
- URIAS, Eduardo, RAMANI, Shyma V. Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence. Journal of International Business Policy, 2020, no. 3, pp. 367–384. [online]. Available at:
- WANG, Lucy Xiaolu. Global Drug Diffusion and Innovation with the Medicines Patent Pool, last revised 29 December 2020. [online]. Available at:
- World Health Organization. Coronavirus disease (COVID-19) pandemic, 5 March 2021. [online]. Available at:
- World Health Organisation. Endorsements of the Solidarity Call to Action. [online]. Available at:
- World Health Organization. International community rallies to support open research and science to fight COVID-19, 29 May 2020. [online]. Available at:
- World Health Organisation. Operationalising the COVID-19 Technology Access Pool (C-TAP): A concept paper. [online]. Available at:
- World Health Organization. Seventy-third WHO Assembly. Agenda item 3, COVID-19 response. Draft resolution, 18 May 2020. [online]. Available at:
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020, 11 March 2020. [online]. Available at:
- World Health Organization. WHO Director-General’s opening remarks at 148th session of the Executive Board, 18 January 2021. [online]. Available at:
- World Health Organization. World Health Organization Assembly Resolution 73, 18 May 2020. [online]. Available at:
- World Intellectual Property Organization. Draft reference document on the exception regarding compulsory licensing, 21 May 2019. [online]. Available at:
- World Trade Organization. Agreement on Trade-Related Aspects of Intellectual Property Rights, in effect as of 1 January 1995. [online]. Available at:
- World Trade Organization. Amendment to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Factsheet. [online]. Available at:
- World Trade Organization. Compulsory licensing of pharmaceuticals and TRIPS. [online]. Available at:
- World Trade Organisation. Council for Trade-Related Aspects of Intellectual Property Rights. Waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19: Communication from India and South Africa, IP/C/W/669, 2 October 2020. [online]. Available at:
- World Trade Organization. Declaration on the TRIPS agreement and public health adopted on 14 November 2001. WT/MIN(01)/DEC/2, 20 November 2001. [online]. Available at:
- World Trade Organization. General Council Decision of the General Council of 30 August 2003. Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health, 1 August 2003. [online]. Available at:
- World Trade Organization, General Council decision of 6 December 2005. Amendment of the TRIPS Agreement. [online]. Available at:
- World Trade Organization. General Council Decision of 30 November 2015. Least developed country members – obligations under Article 70.8 and Article 70.9 of the TRIPS Agreement with respect to pharmaceutical products. [online]. Available at:
- World Trade Organization. Members discuss intellectual property response to the COVID-19 pandemic. [online]. Available at:
- World Trade Organization. Members to continue discussion on proposal for temporary IP waiver in response to COVID-19, 10 December 2020. [online]. Available at:
- World Trade Organization. Protocol Amending the TRIPS Agreement. Done at Geneva on 6 December 2005. Entry into force: 23 January 2017. Status of WTO Legal Instruments – 2021 edition. [online]. Available at:
- World Trade Organization. The separate Doha Declaration explained. [online]. Available at:
- World Trade Organization. The TRIPS Agreement and COVID-19 Information Note, 15 October 2020. [online]. Available at:
- World Trade Organization. TRIPS: Council Work. [online]. Available at:
- World Trade Organization. TRIPS and pharmaceutical patents: fact sheet. [online]. Available at:
- World Trade Organization, World Health Organization, World Intellectual Property Organization. Promoting Access to Medical Technologies and Innovation. Second edition. Intersections between public health, intellectual property and trade, 2020. [online]. Available at:
- ZIMMER, Carl, CORUM, Jonathan, WEE, Sui-Lee. Coronavirus Vaccine Tracker. New York Times, 5 March 2021. [online]. Available at:
Language: English
Page range: 43 - 78
Published on: Aug 19, 2021
Published by: Palacký University Olomouc
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2021 Iza Razija Mešević, published by Palacký University Olomouc
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.